Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Jia ^a   Ren, Shancheng ^b   Piao, Hai Long ^a   Wang, Fubo ^b   Yin, Peiyuan ^a   Xu, Chuanliang ^b   Lu, Xin ^a   Ye, Guozhu ^a   Shao, Yaping ^a   Yan, Min ^a   Zhao, Xinjie ^a   Sun, Yinghao ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; CHOLESTEROL OLEATE; PROSTATE SPECIFIC ANTIGEN; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; TRANSCRIPTOME; TUMOR MARKER;

AGED; AREA UNDER THE CURVE; BLOOD; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENETICS; HUMAN; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC; TUMOR MICROENVIRONMENT;

AGED; AREA UNDER CURVE; BIOMARKERS, TUMOR; CHOLESTEROL ESTERS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; ROC CURVE; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTOME; TUMOR MICROENVIRONMENT;

EID: 84958559571     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20984     Document Type: Article

References (49)

1. Jemal, A. et al. Global cancer statistics. CA. Cancer J. Clin. 61, 69-90 (2011).
2. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer Statistics, 2014. Ca-cancer J Clin 64, 9-29 (2014).
3. Thompson, I. M. et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < = 4.0 ng per milliliter. New Engl J Med 350, 2239-2246 (2004).
4. Draisma, G. et al. Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context. J Natl Cancer I 101, 374-383 (2009).
5. Barry, M. J. Screening for Prostate Cancer-The Controversy That Refuses to Die. New Engl J Med 360, 1351-1354 (2009).
6. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20 (2008).
7. Santos, C. R. & Schulze, A. Lipid metabolism in cancer. FEBS J. 279, 2610-2623 (2012).
8. Wymann, M. P. & Schneiter, R. Lipid signalling in disease. Nature Reviews Molecular Cell Biology 9, 162-176 (2008).
9. Wenk, M. R. The emerging field of lipidomics. Nat Rev Drug Discov 4, 594-610 (2005).
10. Eberlin, L. S. et al. Alteration of the lipid profile in lymphomas induced by MYC overexpression. Proceedings of the National Academy of Sciences of the United States of America 111, 10450-10455 (2014).
11. Kamphorst, J. J. et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proceedings of the National Academy of Sciences of the United States of America 110, 8882-8887 (2013).
12. Hilvo, M. et al. Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression. Cancer Res. 71, 3236-3245 (2011).
13. Tamura, K. et al. Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism. Cancer Res. 69, 8133-8140 (2009).
14. Yang, P. Y. et al. Arachidonic acid metabolism in human prostate cancer. Int J Oncol 41, 1495-1503 (2012).
15. Leon, C. G. et al. Alterations in Cholesterol Regulation Contribute to the Production of Intratumoral Androgens During Progression to Castration-Resistant Prostate Cancer in a Mouse Xenograft Model. Prostate 70, 390-400 (2010).
16. Krycer, J. R. & Brown, A. J. Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective. Bba-rev Cancer 1835, 219-229 (2013).
17. Yue, S. et al. Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness. Cell Metab. 19, 393-406 (2014).
18. Zhou, X. C. et al. Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics. PLoS ONE 7, (2012).
19. Min, H. K., Lim, S., Chung, B. C. & Moon, M. H. Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer. Anal Bioanal Chem 399, 823-830 (2011).
20. Zang, X. et al. Feasibility of Detecting Prostate Cancer by Ultraperformance Liquid Chromatography-Mass Spectrometry Serum Metabolomics. J Proteome Res 13, 3444-3454 (2014).
21. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
22. Trock, B. J. Application of metabolomics to prostate cancer. Urol Oncol-semin Ori 29, 572-581 (2011).
23. Budhu, A. et al. Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes. Gastroenterology 144, 1066-+ (2013).
24. Jain, M. et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation. Science 336, 1040-1044 (2012).
25. Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7, 763-777 (2007).
26. Engelmann, B. & Wiedmann, M. K. H. Cellular phospholipid uptake: Flexible paths to coregulate the functions of intracellular lipids. Bba-mol Cell Biol L 1801, 609-616 (2010).
27. Hermansson, M., Hokynar, K. & Somerharju, P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog Lipid Res 50, 240-257 (2011).
28. Shindou, H. & Shimizu, T. Acyl-CoA: lysophospholipid acyltransferases. J Biol Chem 284, 1-5 (2009).
29. Tosi, M. R. & Tugnoli, V. Cholesteryl esters in malignancy. Clin. Chim. Acta 359, 27-45 (2005).
30. Schmitz, G., Langmann, T. & Heimerl, S. Role of ABCG1 and other ABCG family members in lipid metabolism. Journal of lipid research 42, 1513-1520 (2001).
31. Oram, J. F. & Vaughan, A. M. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Current opinion in lipidology 11, 253-260 (2000).
32. Ouimet, M. & Moore, K. J. A big role for small RNAs in HDL homeostasis. Journal of Lipid Research 54, 1161-1167 (2013).
33. Rhainds, D. & Brissette, L. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking: Defining the rules for lipid traders. The International Journal of Biochemistry & Cell Biology 36, 39-77 (2004).
34. Zadra, G., Priolo, C., Patnaik, A. & Loda, M. New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK. Clin. Cancer Res. 16, 3322-3328 (2010).
35. Rysman, E. et al. De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation. Cancer Res. 70, 8117-8126 (2010).
36. Koeberle, A. et al. Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding. Proceedings of the National Academy of Sciences of the United States of America 110, 2546-2551 (2013).
37. Park, J. B. et al. Phospholipase signalling networks in cancer. Nat Rev Cancer 12, 782-792 (2012).
38. Sved, P. et al. Oncogenic action of secreted phospholipase A(2) in prostate cancer. Cancer Res. 64, 6934-6940 (2004).
39. Wang, D. Z. & Dubois, R. N. Eicosanoids and cancer. Nat Rev Cancer 10, 181-193 (2010).
40. Montgomery, R. B. et al. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth. Cancer Res. 68, 4447-4454 (2008).
41. Bozza, P. T. & Viola, J. P. B. Lipid droplets in inflammation and cancer. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 82, 243-250 (2010).
42. Mao, X. et al. Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis. Cancer Res. 70, 5207-5212 (2010).
43. Twiddy, A. L., Cox, M. E. & Wasan, K. M. Knockdown of scavenger receptor Class B Type I reduces prostate specific antigen secretion and viability of prostate cancer cells. Prostate 72, 955-965 (2012).
44. Hoene, M., Li, J., Häring, H.-U., Weigert, C., Xu, G. & Lehmann, R. The lipid profile of brown adipose tissue is sex-specific in mice. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1841, 1563-1570 (2014).
45. Fahy, E. et al. Update of the LIPID MAPS comprehensive classification system for lipids. Journal of lipid research 50, S9-S14 (2009).
46. Ren, S. C. et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res. 22, 806-821 (2012).
47. Saeed, A. et al. TM4: a free, open-source system for microarray data management and analysis. BioTechniques 34, 374 (2003).
48. Kanehisa, M. et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199-D205 (2014).
49. Hsu, S.-D. et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 42, D78-D85 (2014).